Skip to main content
OpenTrials

Clinical trial condition

Interstitial Lung Diseases

Explore clinical trials studying Interstitial Lung Diseases. Study availability and eligibility vary by location and protocol.

30 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Interstitial Lung Diseases trial results

Recruiting

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

NCT07540988

Conditions
Interstitial Lung Diseases, Lung Diseases, Lung Diseases, Interstitial, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Newport Native MD, Inc Newport Beach, California, United States
  • Clinical Research Specialists LLC - Kissimmee Kissimmee, Florida, United States
View all 166 locations
View Trial Details
Recruiting

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

NCT06806592

Conditions
Interstitial Lung Diseases, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-Arizona Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Paradigm Clinical Research - San Diego San Diego, California, United States
View all 153 locations
View Trial Details
Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

NCT07201922

Conditions
Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases, +3 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Clinical Research Specialists LLC - Kissimmee Kissimmee, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 55 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +10 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details

Related conditions